Corona Remedies IPO Day 3: Check Latest GMP, Subscription Status & Key Highlights
The ₹655.37 crore initial public offering (IPO) of Corona Remedies enters its final day of bidding today, 10 December 2025. Till the end of day 2, the IPO received a total subscription of 9.33 times.
Corona Remedies IPO: Issue Details
- Issue Size: The Corona Remedies IPO is a book-building issue of ₹655.37 crore, consisting entirely of an offer for sale (OFS) of 0.62 crore shares.
- Price Band: The price band is set at ₹1008-₹1062 per share.
- Lot Size: 14 shares
- Minimum Investment: ₹14,112 (for retail investors)
- Book-running lead managers: JM Financial Limited, IIFL Capital Services Limited, Kotak Mahindra Capital Company Limited
- Registrar: Bigshare Services Private Limited
- Listing: The shares are proposed to be listed on the NSE and the BSE on December 15, 2025.
Corona Remedies IPO Day 3: Subscription Details
[10-December-2025 11:09:00 hrs]
|
Investor Category |
Subscription (Times) |
|
Qualified Institutional Buyers (QIBs) |
1.82 |
|
Non-Institutional Investors |
68.76 |
|
Retail Individual Investors (RIIs) |
10.97 |
|
Employees |
5.95 |
|
Total |
20.54 |
Utilisation of IPO Proceeds
As the Corona Remedies issue is entirely an offer for sale, the company will not receive any proceeds, and they will be allocated directly to selling shareholders.
Corona Remedies IPO GMP
According to media reports, the Grey Market Premium (GMP) of the Corona Remedies IPO is reported at ₹270 over the IPO price. The shares are expected to list at around a 25.42% premium.
Corona Remedies Business Overview
Corona Remedies is a pharmaceutical company engaged in the development, manufacturing, and marketing of branded formulations across key therapeutic categories, including women’s health, cardio-diabetes, pain and musculoskeletal care, urology, and a range of multispecialty segments.
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here